MedTrace Logo

Noradrenergic Activity and Attention

NCT05120713 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

Older adults demonstrate increased distractibility by task-irrelevant information which contributes to general cognitive impairment. However, it is yet unclear how changes in noradrenergic activity during aging influences attentional control. In the current study, tonic noradrenergic activity will be increased or decreased to investigate its behavioral and neural effects on attentional control.

Conditions

  • Aging

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-11-20
Completion
2023-11-20

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05120713 on ClinicalTrials.gov